TP53 and non-small cell lung carcinoma: In that study, the authors evaluated TP53 mutation in NSCLC, namely, adenocarcinoma and squamous cell carcinoma, while in our study TP53 mutation and its correlation with ERs were evaluated exclusively in adenocarcinoma.